CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) treatment has been successfully used on a patient for the first time. Infant KJ Muldoon was born with the rare disorder Carbamoyl Phosphate Synthetase 1 deficiency (CPS1) and received CRISPR gene-editing as an alternative to a liver transplant. Read more.